10.45
1.23%
-0.13
前日終値:
$10.58
開ける:
$10.57
24時間の取引高:
1.69M
Relative Volume:
0.64
時価総額:
$1.20B
収益:
$2.35B
当期純損益:
$-74.42M
株価収益率:
-11.12
EPS:
-0.94
ネットキャッシュフロー:
$150.93M
1週間 パフォーマンス:
+3.47%
1か月 パフォーマンス:
-7.11%
6か月 パフォーマンス:
-55.19%
1年 パフォーマンス:
-64.47%
Evolent Health Inc Stock (EVH) Company Profile
名前
Evolent Health Inc
セクター
電話
571-389-6000
住所
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
EVH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.45 | 1.20B | 2.35B | -74.42M | 150.93M | -0.94 |
VEEV
Veeva Systems Inc
|
233.26 | 37.87B | 2.66B | 665.91M | 1.08B | 4.05 |
SOLV
Solventum Corp
|
74.06 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
DOCS
Doximity Inc
|
59.10 | 11.03B | 516.85M | 174.11M | 217.38M | 0.87 |
HQY
Healthequity Inc
|
110.42 | 9.57B | 1.15B | 96.70M | -161.99M | 1.09 |
TEM
Tempus Ai Inc
|
57.39 | 9.04B | 640.44M | -743.28M | -206.93M | -11.29 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | 開始されました | Needham | Buy |
2024-12-03 | 繰り返されました | BTIG Research | Buy |
2024-11-08 | ダウングレード | Stephens | Overweight → Equal-Weight |
2024-10-11 | 開始されました | KeyBanc Capital Markets | Overweight |
2024-08-09 | アップグレード | Truist | Hold → Buy |
2024-04-22 | 開始されました | Citigroup | Buy |
2024-03-01 | 開始されました | Oppenheimer | Outperform |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
2023-10-16 | 開始されました | UBS | Buy |
2023-04-12 | 開始されました | Stephens | Overweight |
2022-11-01 | 開始されました | Truist | Hold |
2022-07-29 | 開始されました | RBC Capital Mkts | Outperform |
2022-03-30 | 開始されました | Guggenheim | Buy |
2021-11-18 | アップグレード | JP Morgan | Neutral → Overweight |
2021-04-29 | 再開されました | JP Morgan | Neutral |
2021-01-07 | 開始されました | BTIG Research | Buy |
2020-07-06 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-06-05 | ダウングレード | Goldman | Buy → Neutral |
2020-06-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2018-10-05 | 再開されました | Leerink Partners | Outperform |
2018-06-04 | 開始されました | Piper Jaffray | Overweight |
2018-04-24 | 再開されました | JP Morgan | Neutral |
2017-09-20 | 開始されました | KeyBanc Capital Mkts | Overweight |
2017-06-02 | 開始されました | Robert W. Baird | Outperform |
2017-03-14 | 開始されました | Oppenheimer | Outperform |
2017-01-13 | アップグレード | Wells Fargo | Market Perform → Outperform |
2016-10-28 | 再開されました | JP Morgan | Overweight |
2016-08-05 | 繰り返されました | FBR Capital | Outperform |
2016-07-26 | 開始されました | Jefferies | Buy |
2016-07-13 | 繰り返されました | FBR Capital | Outperform |
2016-03-29 | 開始されました | FBR Capital | Outperform |
2016-01-06 | 開始されました | Canaccord Genuity | Buy |
2015-06-30 | 開始されました | Goldman | Buy |
2015-06-30 | 開始されました | JP Morgan | Overweight |
2015-06-30 | 開始されました | Leerink Partners | Outperform |
2015-06-30 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Evolent Health Inc (EVH) 最新ニュース
Evolent Health Inc. secures $200 million in credit facilities - MSN
FY2024 EPS Estimates for Evolent Health Lowered by Analyst - MarketBeat
Evolent Health (NYSE:EVH) Trading 6.7% HigherTime to Buy? - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Nasdaq
Evolent Health Q4 Earnings Coming: Key Dates You Need to Know + 3 Major Conference Appearances - StockTitan
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $18.00 - Defense World
Canaccord Genuity Group Cuts Evolent Health (NYSE:EVH) Price Target to $16.00 - Defense World
Evolent Health's SWOT analysis: healthcare tech stock faces challenges amid growth - MSN
Evolent Health (NYSE:EVH) Given New $18.00 Price Target at Oppenheimer - MarketBeat
Evolent Health's SWOT analysis: stock faces challenges amid growth potential By Investing.com - Investing.com South Africa
Canaccord cuts Evolent Health target to $16, maintains Buy - MSN
Evolent Health’s SWOT analysis: stock faces challenges amid growth potential - Investing.com Nigeria
Evolent Health (NYSE:EVH) Shares Gap Down on Analyst Downgrade - Defense World
JMP cuts Evolent Health target to $12, keeps Outperform rating - MSN
Evolent Health's SWOT analysis: stock faces challenges amid growth potential - MSN
Evolent Health’s SWOT analysis: healthcare tech stock faces challenges amid growth - Investing.com Nigeria
JMP cuts Evolent Health target to $12, keeps Outperform rating By Investing.com - Investing.com Canada
Evolent Health (NYSE:EVH) Shares Gap Down Following Analyst Downgrade - MarketBeat
Brighton Jones LLC Makes New Investment in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Research Analysts’ Recent Ratings Changes for Evolent Health (EVH) - Defense World
Evolent Health's SWOT analysis: healthcare tech stock faces challenges amid growth By Investing.com - Investing.com South Africa
Canaccord Genuity Group Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Canaccord cuts Evolent Health target to $16, maintains Buy By Investing.com - Investing.com Canada
Evolent Health price target lowered to $20 from $29 at BTIG - Yahoo Finance
Stephens Lowers Evolent Health (NYSE:EVH) Price Target to $12.00 - Defense World
Evolent Health (NYSE:EVH) Hits New 1-Year Low Following Analyst Downgrade - Defense World
Evolent Health (NYSE:EVH) Reaches New 1-Year Low on Analyst Downgrade - MarketBeat
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $15.00 - MarketBeat
Truist updates Evolent Health stock outlook on Q4 profitability adjustments - MSN
Truist updates Evolent Health stock outlook on Q4 profitability adjustments By Investing.com - Investing.com Canada
Stephens cuts Evolent Health stock target, retains equal weight rating - MSN
Evolent Health (NYSE:EVH) Price Target Lowered to $12.00 at Stephens - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Receives $21.92 Average PT from Analysts - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Evolent Health (NYSE:EVH) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Evolent Health (NYSE:EVH) Price Target Lowered to $14.00 at UBS Group - MarketBeat
Unlocking Q3 Potential of Evolent Health (EVH): Exploring Wall Street Estimates for Key Metrics - MSN
Evolent Health FY2024 EPS Estimate Boosted by William Blair - Defense World
Evolent Health FY2024 EPS Forecast Lifted by William Blair - MarketBeat
Evolent Health (NYSE:EVH) Reaches New 12-Month LowHere's Why - MarketBeat
Evolent Health Stock Price (NYSE: EVH) Hit 52 Week Lows as Guidance Falls Short - AskTraders
Evolent Health (NYSE:EVH) Stock Price Down 2% Following Analyst Downgrade - MarketBeat
Evolent Health (NYSE:EVH) Shares Down 2% After Analyst Downgrade - Defense World
Evolent Health stock hits 52-week low at $10.52 amid market challenges - Investing.com Canada
Evolent Health Inc (EVH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):